Psychedelic Participant Advocacy Network

The Psychedelic Participant Advocacy Network (PsyPAN) is a UK-based non-profit organization founded in 2021 by Ian Roullier and Leonie Schneider, both former psychedelic clinical trial participants. PsyPAN is dedicated to connecting and empowering individuals who have participated in psychedelic clinical trials or received legal psychedelic-assisted therapy. The organization aims to amplify the patient voice, improve participant safety and wellbeing, and establish sector-wide best practices by feeding lived experiences back to trial sponsors, clinicians, and treatment centers. PsyPAN offers consultancy and accreditation services to help clinical trials and treatment centers design and deliver ethical, participant-centered care.